GLULP4: A Potential Drug Target and Biomarker (G392305)

Target Name: GLULP4

NCBI ID: G392305

Other Name(s): GLULP | Glutamate-ammonia ligase (glutamine synthetase) pseudogene 4 | glutamate-ammonia ligase pseudogene 4

GLULP4: A Potential Drug Target and Biomarker

GLULP4 (G-CSF-1-like protein 4) is a protein that is expressed in various tissues, including the brain, heart, and kidneys, and has been shown to play a role in various physiological processes. GLULP4 has also been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

GLULP4 is a member of the G-CSF family, which includes several other proteins that play a role in the production and regulation of granulocyte-colony stimulating factor (GCGF), a protein that is involved in the development and function of granulocytes, a type of white blood cell that plays a critical role in immune responses and inflammation. The G-CSF family of proteins is also known as the GLULP family, as the name is derived from the last two letters of the protein name.

GLULP4 is a 21-kDa protein that is expressed in various tissues, including the brain, heart, and kidneys. It is highly expressed in the brain and has been shown to play a role in the development and function of neural cells, including neurons and glial cells. GLULP4 has also been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and survival.

GLULP4 has also been identified as a potential drug target for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, GLULP4 has been shown to be involved in the development and progression of various types of cancer, including neurobladder cancer and breast cancer. Additionally, GLULP4 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

GLULP4 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, GLULP4 has been shown to be involved in the diagnosis and prognosis of various types of cancer, including breast and ovarian cancer. Additionally, GLULP4 has been shown to be involved in the diagnosis and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In conclusion, GLULP4 is a protein that has been shown to play a critical role in various physiological processes and has been identified as a potential drug target and biomarker for several diseases. Further research is needed to fully understand the role of GLULP4 in these processes and to develop effective treatments for GLULP4-related diseases.

Protein Name: Glutamate-ammonia Ligase Pseudogene 4

More Common Targets